MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 25.02.2026
Land |
 Irland |
IPO-Jahr |
1991 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
165 M |
Marktkapitalisierung |
$ 4.97 B |
EBITDA (LTM) |
$ 287 M |
P/E (LTM) |
16.87 |
P/S (LTM) |
3.35 |
EPS (LTM) |
1.78 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Alector
ALEC
|
$ 2.11 | -13.17 % | $ 217 M | Nasdaq Global Select Market,SPB |  USA |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Apellis Pharmaceuticals
APLS
|
$ 20.52 | -2.12 % | $ 2.59 B | Nasdaq Global Select Market,SPB | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Axsome Therapeutics
AXSM
|
$ 164.13 | 0.15 % | $ 8.17 B | Nasdaq Global Market,SPB | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Aytu BioScience
AYTU
|
$ 2.49 | -3.11 % | $ 15.6 M | Nasdaq Capital Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
BridgeBio Pharma
BBIO
|
$ 64.24 | -3.37 % | $ 12.3 B | Nasdaq Global Select Market,SPB | USA |
 |
BioAtla
BCAB
|
$ 0.18 | -26.92 % | $ 8.6 M | Nasdaq Global Select Market | USA |
 |
BioCardia
BCDA
|
$ 1.37 | 6.2 % | $ 29 M | Nasdaq Global Select Market | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
$ 8.61 | -1.66 % | $ 1.78 B | Nasdaq Global Select Market | USA |
 |
Black Diamond Therapeutics
BDTX
|
$ 2.4 | -3.04 % | $ 132 M | Nasdaq Global Select Market,SPB | USA |
 |
Beam Therapeutics
BEAM
|
$ 28.29 | -0.6 % | $ 2.8 B | Nasdaq Global Select Market | USA |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market |  Canada |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$ 11.47 | -0.43 % | $ 742 M | NYSE | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Biogen
BIIB
|
$ 187.68 | -2.16 % | $ 27.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
BioVie
BIVI
|
$ 1.38 | -0.01 % | $ 2.04 M | Nasdaq Capital Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
BioLineRx Ltd.
BLRX
|
$ 2.91 | 2.83 % | $ 908 M | Nasdaq Capital Market |  Israel |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
BioMarin Pharmaceutical
BMRN
|
$ 60.68 | -1.7 % | $ 11.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Bristol-Myers Squibb Company
BMY
|
$ 62.54 | 0.27 % | $ 127 B | NYSE,SPB | USA |
 |
Benitec Biopharma
BNTC
|
$ 10.85 | -0.5 % | $ 447 M | Nasdaq Capital Market | USA |
 |
BioNTech SE
BNTX
|
$ 109.85 | -0.34 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
BioXcel Therapeutics
BTAI
|
$ 1.63 | -2.69 % | $ 4.13 M | Nasdaq Global Select Market,SPB | USA |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | Canada |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
Burford Capital Limited
BUR
|
$ 8.6 | 1.9 % | $ 1.39 B | NYSE | Britain |
 |
Athira Pharma
ATHA
|
- | - | $ 269 M | Nasdaq Global Select Market | USA |